BNP PARIBAS FINANCIAL MARKETS - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$2,274
+308.3%
976
+233.1%
0.00%
Q4 2022$557
-99.6%
293
+343.9%
0.00%
Q3 2022$141,000
-95.1%
66
-93.5%
0.00%
Q2 2022$2,858,000
+1131.9%
1,010
+2785.7%
0.00%
Q2 2021$232,000350.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders